case_images: PMC9987211_01
case_images: Patient's timeline. TNBC, triple-negative breast cancer; CT, chemotherapy; DFS, disease-free survival; PFS, progression-free survival; PD, progressive disease; CR, complete response; WBRT, whole-brain radiotherapy; m, months.
case_images: fonc-13-1139372-g001.jpg
case_images: PMC9987211_01_fonc-13-1139372-g001.jpg
case_images: f1
case_images: Radiological evaluation of the patient's lung metastases (A, B) before, (C, D) after 3.5 months, and (E, F) after 7 months of treatment with sacituzumab govitecan.
case_images: fonc-13-1139372-g002.jpg
case_images: PMC9987211_01_fonc-13-1139372-g002.jpg
case_images: f2
case_images: Intracranial disease (A) before, (B) after 3.5 months, and (C) after 7 months of treatment with sacituzumab govitecan. (D) Intracranial response was maintained after systemic progression.
case_images: fonc-13-1139372-g003.jpg
case_images: PMC9987211_01_fonc-13-1139372-g003.jpg
case_images: f3